By Researchers from The University of Texas MD Anderson Cancer Center are presenting compelling findings from three clinical trials at the 2022 American Society of Hematology Annual Meeting.
Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias
Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.
Comments